Roy Freeman
Director/Board Member chez INHIBIKASE THERAPEUTICS, INC.
Fortune : - $ au 31/03/2024
Profil
Roy Freeman is the founder of NeuroBo Therapeutics, Inc., Cnd Life Sciences, Inc. He currently holds three positions: Director-Neurology Department at Beth Israel Deaconess Medical Center, Inc., Independent Director at Inhibikase Therapeutics, Inc., and Professor-Neurology at Harvard Medical School.
Previously, he held positions such as Chairman-Autonomic Section at American Academy of Neurology, Chairman at World Federation of Neurology, and President at American Autonomic Society.
He received his undergraduate degree from the University of Cape Town.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Roy Freeman
| Sociétés | Poste | Début |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Director/Board Member | 22/12/2020 |
| Harvard Medical School | Corporate Officer/Principal | - |
Beth Israel Deaconess Medical Center, Inc.
 Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Corporate Officer/Principal | - |
Cnd Life Sciences, Inc.
 Cnd Life Sciences, Inc. Medical/Nursing ServicesHealth Services Cnd Life Sciences, Inc. is a company based in an undisclosed location that aims to transform the diagnosis and treatment of neurodegenerative diseases. The company is based in Scottsdale, AZ. The company operates a CLIA-certified and CAP-accredited laboratory and has launched the Syn-One test, the world's first commercially available test that detects and visualizes phosphorylated alpha-synuclein in cutaneous nerves with high accuracy to aid the diagnosis of Parkinson's disease and related disorders. Cnd Life Sciences has scientific collaborations with biopharmaceutical companies and has been awarded three NIH SBIR grants to advance the clinical utility of the Syn-One test. The company allows clinicians to access objective pathological insights on diseases that are often difficult to diagnose and apply those insights to generate better outcomes for patients. The company was founded in 2017 by Todd Dylan Levine, Christopher Gibbons, Roy Freeman, and the CEO is Richard J. Morello. | Founder | - |
Anciens postes connus de Roy Freeman
| Sociétés | Poste | Fin |
|---|---|---|
World Federation of Neurology
 World Federation of Neurology Miscellaneous Commercial ServicesCommercial Services World Federation of Neurology operates as an association of national neurological societies. The firm promotes neurology worldwide, and to improve prevention and diagnosis management for patients. The company was founded in 1957 and is headquartered in Richmond, the United Kinmgdom. | Chairman | - |
American Academy of Neurology
 American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services American Academy of Neurology operates a professional society which represents neurologists and neuroscientists. The company was founded in 1948 and is headquartered in Minneapolis, MN. | Corporate Officer/Principal | - |
| American Autonomic Society | President | - |
Neurobo Therapeutics, Inc.
 Neurobo Therapeutics, Inc. BiotechnologyHealth Technology NeuroBo Therapeutics, Inc. engages in the development and research of treatment for neurodegenerative diseases. It focuses on novel therapies for diabetic neuropathic pain and central nervous system diseases. The company was founded by Roy Freeman and is headquartered in Boston, MA. | Founder | - |
Formation de Roy Freeman
| University of Cape Town | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Beth Israel Deaconess Medical Center, Inc.
Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Health Services |
American Academy of Neurology
American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services American Academy of Neurology operates a professional society which represents neurologists and neuroscientists. The company was founded in 1948 and is headquartered in Minneapolis, MN. | Commercial Services |
World Federation of Neurology
World Federation of Neurology Miscellaneous Commercial ServicesCommercial Services World Federation of Neurology operates as an association of national neurological societies. The firm promotes neurology worldwide, and to improve prevention and diagnosis management for patients. The company was founded in 1957 and is headquartered in Richmond, the United Kinmgdom. | Commercial Services |
Neurobo Therapeutics, Inc.
Neurobo Therapeutics, Inc. BiotechnologyHealth Technology NeuroBo Therapeutics, Inc. engages in the development and research of treatment for neurodegenerative diseases. It focuses on novel therapies for diabetic neuropathic pain and central nervous system diseases. The company was founded by Roy Freeman and is headquartered in Boston, MA. | Health Technology |
| American Autonomic Society | |
Cnd Life Sciences, Inc.
Cnd Life Sciences, Inc. Medical/Nursing ServicesHealth Services Cnd Life Sciences, Inc. is a company based in an undisclosed location that aims to transform the diagnosis and treatment of neurodegenerative diseases. The company is based in Scottsdale, AZ. The company operates a CLIA-certified and CAP-accredited laboratory and has launched the Syn-One test, the world's first commercially available test that detects and visualizes phosphorylated alpha-synuclein in cutaneous nerves with high accuracy to aid the diagnosis of Parkinson's disease and related disorders. Cnd Life Sciences has scientific collaborations with biopharmaceutical companies and has been awarded three NIH SBIR grants to advance the clinical utility of the Syn-One test. The company allows clinicians to access objective pathological insights on diseases that are often difficult to diagnose and apply those insights to generate better outcomes for patients. The company was founded in 2017 by Todd Dylan Levine, Christopher Gibbons, Roy Freeman, and the CEO is Richard J. Morello. | Health Services |
